Pain Therapeutics gains on abuse-deterrence data

Pain Therapeutics Inc. (NASDAQ:PTIE) gained $4.82 (114%) to $9.04 on Tuesday after its Remoxy ER oxycodone extended release met the primary endpoint in

Read the full 238 word article

User Sign In